SCHEMBL18514972

SCHEMBL18514972

CCc1cc(Br)c(OCc2c(F)cccc2NC(=O)OC)cc1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.38
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 1/20 0.38
RAB9A P51151 7/20 0.38
NPC1 O15118 5/20 0.38
PTGER1 P34995 2/20 0.38
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
KDM4E B2RXH2 1/20 0.35
CASP3 P42574 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
SLC22A12 Q96S37 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18748860 0.91 RAB9A (0.40) LMNAALDH1A1SMN1; SMN2GAARAB9A
SCHEMBL18514947 0.91 SLC22A12 (0.39) LMNAALDH1A1SMN1; SMN2GAARAB9A
SCHEMBL18760700 0.90 MEN1 (0.37) LMNAALDH1A1SMN1; SMN2GAARAB9A
SCHEMBL18514809 0.90 RAB9A (0.39) LMNAALDH1A1RAB9ANPC1PTGER1
SCHEMBL18514929 0.90 SMN1; SMN2 (0.36) LMNAALDH1A1SMN1; SMN2GAARAB9A
SCHEMBL18513878 0.90 RAB9A (0.39) LMNAALDH1A1RAB9ANPC1PTGER1
SCHEMBL18514810 0.90 RAB9A (0.39) LMNAALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL18515003 0.90 MEN1 (0.35) LMNAALDH1A1SMN1; SMN2GAARAB9A
SCHEMBL18514602 0.90 ALDH1A1 (0.41) LMNAALDH1A1SMN1; SMN2GAARAB9A
SCHEMBL18514825 0.89 ALDH1A1 (0.37) LMNAALDH1A1SMN1; SMN2GAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9788547-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-17 US disclosed
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 US disclosed
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 US disclosed
EP-3130584-A1 AROMATIC COMPOUND AND USES THEREOF Sumitomo Chemical Company Limited (JP) 2017-02-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-0 LMNA 2808/4885ALDH1A1 1238/4885SMN1; SMN2 3813/4885
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-10 LMNA 3163/4885ALDH1A1 1416/4885SMN1; SMN2 4067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.